[Federal Register: July 13, 2004 (Volume 69, Number 133)]
[Notices]
[Page 42068]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr13jy04-78]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on April 22 and 28, 2004,
Noramco, Inc., 1440 Olympic Drive, Athens, Georgia 30601-1645, made
application by letter to the Drug Enforcement Administration (DEA) for
registration as a bulk manufacturer of the basic classes of controlled
substances listed below:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Codeine-N-Oxide (9053)..................... I
Morphine-N-Oxide (9307).................... I
Hydromorphone-N-Oxide (9150)............... II
------------------------------------------------------------------------
The firm plans to manufacture small quantities of the Schedule I
products for internal testing; the Schedule II product will be
manufactured for distribution to a customer.
Any other such applicant and any person who is presently registered
with DEA to manufacture such substance may file comments or objections
to the issuance of the proposed registration.
Any such comments or objections may be addressed, in quintuplicate,
to the Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration, United States Department of Justice,
Washington, DC 20537, Attention: Federal Register Representative,
Office of Chief Counsel (CCD) and must be filed no later than September
13, 2004.
Dated: June 28, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 04-15773 Filed 7-12-04; 8:45 am]
BILLING CODE 4410-09-M